BridgeMD
Compares treatment options for Vestibular Neuritis
Official title Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis
ClinicalTrials.gov ID: NCT04678167
What this study is testing
- What it's testing
- Vestibular neuritis is a brutal and continuous dizzying syndrome of peripheral (vestibular) origin without cochlear or other associated involvement. Specifically, vestibular neuritis is inflammation of the nerve that innervates the vestibular canals (the inner ear).
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- adult patients,
- patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea
- patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear
- patient with a postural deviation towards the affected ear;
- vestibular hyporeflexia measured at the caloric tests greater than 25%
You likely can't join if
- patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days
- patient with associated hearing loss or tinnitus
- patient with an motor ocular abnormality of central origin
- patient refusal or inability to consent
See the full eligibility criteria
- adult patients,
- patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea
- patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear
- patient with a postural deviation towards the affected ear;
- vestibular hyporeflexia measured at the caloric tests greater than 25%
- patient who has given free, enlighten and written consent
- patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days
- patient with associated hearing loss or tinnitus
- patient with an motor ocular abnormality of central origin
- patient refusal or inability to consent
The study team makes the final eligibility decision.
Where it's taking place
- Brest, France
- Morlaix, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brest, France; Morlaix, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.